Show pagesourceBacklinksCite current pageExport to PDFBack to top Share via Share via... Twitter LinkedIn Facebook Pinterest Telegram WhatsApp Yammer Reddit TeamsRecent ChangesSend via e-MailPrintPermalink × CAR-T cell therapy in Neurosurgery Adoptive cell therapy with macrophage-drug conjugates facilitates cytotoxic drug transfer and immune activation in glioblastoma modelsTargeting tumor metabolism to augment CD8<sup>+</sup> T cell anti-tumor immunityCD70 CAR-T cells empowered by TS-2021 through ex vivo transduction show potent antitumor efficacy against glioblastomaThe hotspots and publication trends in glioblastoma and CAR-T immunotherapy: A bibliometric analysisUnraveling the immunosuppressive microenvironment of glioblastoma and advancements in treatmentThe CXCL1-CXCR2 Axis as a Component of Therapy Resistance, a Source of Side Effects in Cancer Treatment, and a Therapeutic TargetThe safety and feasibility of multiple intrathecal injections of allogenic NK cells in pediatrics with refractory/recurrent brain tumorsTransient mRNA CAR T cells targeting GD2 provide dose-adjusted efficacy against diffuse midline glioma and high grade glioma models Glioblastoma CAR-T cell therapy Glioblastoma CAR-T cell therapy. car-t_cell_therapy_in_neurosurgery.txt Last modified: 2024/06/07 02:55by 127.0.0.1